Sartorius Stedim Biotech – offering innovative single-use technologies for advanced bioprocessing
Posted: 30 August 2019 | Sartorius | No comments yet
Innovations in single-use process automation are driving single-use adoption into commercial biologics facilities. Here, Sartorius Stedim Biotech (SSB) shares its latest service offering.
What bioprocessing technology, and specifically single-use solutions, does your company offer?
SSB provides the industry’s most comprehensive portfolio of single-use technologies and services adapted to the majority of bioprocessing needs, including end-to-end upstream and downstream processing of monoclonal antibodies (mAbs), vaccines, antibody-drug conjugates (ADCs) and regenerative medicines up to commercial scales.
